Devin Kepchia - Publications

Affiliations: 
2017 University of Miami, Coral Gables, FL 

5/12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Liang Z, Soriano-Castell D, Kepchia D, Duggan BM, Currais A, Schubert D, Maher P. Corrigendum to "Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors" [Free Radic. Biol. Med. 180 (2020 Feb 20) 33-51]. Free Radical Biology & Medicine. 184: 16. PMID 35381547 DOI: 10.1016/j.freeradbiomed.2022.03.022  0.336
2019 Kepchia D, Xu P, Terryn R, Castro A, Schürer SC, Leal WS, Luetje CW. Use of machine learning to identify novel, behaviorally active antagonists of the insect odorant receptor co-receptor (Orco) subunit. Scientific Reports. 9: 4055. PMID 30858563 DOI: 10.1038/S41598-019-40640-4  0.654
2017 Kepchia D, Sherman B, Haddad R, Luetje CW. Mammalian odorant receptor tuning breadth persists across distinct odorant panels. Plos One. 12: e0185329. PMID 28945824 DOI: 10.1371/Journal.Pone.0185329  0.615
2017 Kepchia D, Moliver S, Chohan K, Phillips C, Luetje CW. Correction: Inhibition of insect olfactory behavior by an airborne antagonist of the insect odorant receptor co-receptor subunit. Plos One. 12: e0183009. PMID 28771601 DOI: 10.1371/journal.pone.0183009  0.624
2017 Kepchia D, Moliver S, Chohan K, Phillips C, Luetje CW. Inhibition of insect olfactory behavior by an airborne antagonist of the insect odorant receptor co-receptor subunit. Plos One. 12: e0177454. PMID 28562598 DOI: 10.1371/journal.pone.0177454  0.662
Low-probability matches (unlikely to be authored by this person)
2019 Schubert D, Kepchia D, Liang Z, Dargusch R, Goldberg J, Maher P. Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease. Molecular Neurobiology. PMID 31104297 DOI: 10.1007/s12035-019-1637-8  0.207
2022 Liang Z, Soriano-Castell D, Kepchia D, Duggan BM, Currais A, Schubert D, Maher P. Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors. Free Radical Biology & Medicine. 180: 33-51. PMID 34999187 DOI: 10.1016/j.freeradbiomed.2022.01.001  0.186
2022 Currais A, Kepchia D, Liang Z, Maher P. The Role of AMP-activated Protein Kinase in Oxytosis/Ferroptosis: Protector or Potentiator? Antioxidants & Redox Signaling. PMID 35243895 DOI: 10.1089/ars.2022.0013  0.078
2022 Kepchia D, Huang L, Currais A, Liang Z, Fischer W, Maher P. The Alzheimer's disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 147: 112648. PMID 35051863 DOI: 10.1016/j.biopha.2022.112648  0.078
2021 Kepchia D, Currais A, Dargusch R, Finley K, Schubert D, Maher P. Geroprotective effects of Alzheimer's disease drug candidates. Aging. 13. PMID 33550278 DOI: 10.18632/aging.202631  0.076
2010 Damerla RR, Knickelbein KE, Kepchia D, Jackson A, Armitage BA, Eckert KA, Opresko PL. Telomeric repeat mutagenicity in human somatic cells is modulated by repeat orientation and G-quadruplex stability. Dna Repair. 9: 1119-29. PMID 20800555 DOI: 10.1016/J.Dnarep.2010.07.014  0.072
2020 Kepchia D, Huang L, Dargusch R, Rissman RA, Shokhirev MN, Fischer W, Schubert D. Diverse proteins aggregate in mild cognitive impairment and Alzheimer's disease brain. Alzheimer's Research & Therapy. 12: 75. PMID 32560738 DOI: 10.1186/S13195-020-00641-2  0.01
Hide low-probability matches.